主权项 |
1. A compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein
R is —(C1-C6)alkylNR2R3, —(C1-C6)alkyl R4;R1 is independently selected from the group consisting halogen, (C1-C6)alkyl, —CN, —CF3, —O—(C1-C6)alkyl, —O-(halo(C1-C6)alkyl), —C(O)—O—(C1-C6)—OH-substituted (C1-C4)alkyl, halo (C1-C6)alkyl, —(C1-C4)alkoxy-OH, —(C1-C4)alkoxy(C1-C4)alkoxy and —S(O)2(C1-C6)alkyl;n is 0, 1, 2, 3;R2 is H or (C1-C6)alkyl;R3 is H, alkyl, halo(C1-C6)alkyl, —(C3-C6)cycloalkyl, —(C1-C3)alkyl-(C3-C6)cycloalkyl optionally substituted with 1 or 2 L1 groups or —C(O)—(C1-C6)alkyl;R4 is —CN, —OH-substituted halo(C1-C6)alkyl, —(C3-C6)cycloalkyl optionally substituted with 1 or 2 L1 groups, —(C3-C5)heterocycloalkyl containing 1-2 heteroatoms selected from N and O optionally substituted with 1 or 2 L1 groups, —C(O)NH2, —C(S)NH2, —C(O)NH—(C1-C4)alkyl, —C(O)NH—(C3-C5)heterocycloalkyl containing 1-2 heteroatoms selected from N and O, —C(O)—NH—(C3-C6)cycloalkyl, —C(O)—(C3-C5)heterocycloalkyl containing 1-2 heteroatoms selected from N and O, —N((C1-C4)alkyl)-C(O)—(C1-C3)alkyl, —N((C1-C4)haloalkyl)-C(O)(C1-C3)alkyl), —S(O)2—(C1-C3)alkyl and —P(O)—((C1-C3)alkoxy)2;L1 is independently selected from the group consisting of —CH3, —NH2, —OH, —C(O)—CH3, ═O and —C(O)—NH2;Ar is selected from the group consisting of phenyl optionally substituted with 1 or 2 L2 groups, and pyridyl optionally substituted with 1 or 2 L2 groups; andL2 is independently selected from the group consisting of: halogen, (C1-C6)alkyl, —CN, —CF3, —O—(C1-C6)alkyl —O-(halo(C1-C6)alkyl), —C(O)—O—(C1-C6)alkyl, —OH— substituted(C1-C6)alkyl, halo(C1-C6)alkyl, —OH-substituted (C1-C4)alkoxy, —(C1-C4)alkoxy(C1-C4)alkoxy and —S(O)2(C1-C6)alkyl. |